FindTrial
Sign In

CMV virus and breast milk

CYTOMEGALOVIRUS SECRETION IN BREASTMILK OF MOTHERS DELIVERING BEFORE 32 WEEKS OF GESTATION- A PROSPECTIVE OBSERVATIONAL STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/05/053246
Enrollment
93
Registered
2023-05-30
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A00-B99- Certain infectious and parasitic diseases

Interventions

None listed

Sponsors

KIMSHEALTH TRIVANDRUM
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All mothers delivering before 32weeks of gestation

Exclusion criteria

Exclusion criteria: Mothers referred from outside after 1week Congenital CMV infection in baby When breast feeding is contraindicated

Design outcomes

Primary

MeasureTime frame
The proportion of mothers of neonates less than 32 weeks gestation or less than 1500 g birth weight who secrete CMV in fresh breast milk.Timepoint: Till CMV PCR report—

Secondary

MeasureTime frame
Clinically relevant outcomes in babies of mothers secreting CMV in breast milkTimepoint: 4months—

Countries

India

Contacts

Public ContactDr FEMITHA POURNAMI

KERALA INSTITUTE OF MEDICAL SCIENCE, TRIVANDRUM

Femi_shifas@yahoo.com9539556593

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026